Górriz J L, Sancho A, Pallardó L M, Amoedo M L, Martín M, Sanz P, Barril G, Selgas R, Salgueira M, Palma A, de la Torre M, Ferreras I
Servicio de Nefrología Hospital Universitario Dr. Peset Avda. Gaspar Aguilar, 90 46017 Valencia.
Nefrologia. 2002;22(1):49-59.
The aim of our study was to analyse patient characteristics, mortality and costs, all of them in relation to whether starting dialysis was planned or unplanned.
A total of 362 patients (227 male and 135 female) from five hospitals of the National Health System, who were started on chronic renal replacement therapy (RRT) during 1996 and 1997 were included. Patients who were started on RRT after acute renal failure were excluded. We carried out a retrospective analysis of the demographic characteristics, patients' conditions at the time of initiating dialysis and outcome and costs at six and thirty-six months of treatment. Patients were classified as planned (PL-D) or unplanned dialysis (UNPL-D), depending on whether or not the patient had a vascular or peritoneal access ready to use for initiating RRT.
One hundred and eighty-six patients (51.4%) started on dialysis in the PL-D group whereas 176 (48.6%) did it as UNPL-D. In this latter group, 135 (37.3% of the total) had previously been monitored by a nephrologist, and 41 (11.3%) initiated dialysis without previous nephrological follow-up. UNPL-D was associated with older age (p < 0.001), non-nephrological follow-up (p < 0.001), diabetes (34.7% vs 22.6%) (p = 0.011), haemodialysis as a first mode of RRT (94.9 vs 81.7%) (p < 0.001), higher comorbidity risk (p < 0.001), dialysis initiation with uraemic symptoms or fluid overload (p < 0.001), increased blood transfusion requirement (p < 0.001) and lower serum albumin (p < 0.001), creatinine clearance (p < 0.001), haemoglobin concentration (p < 0.001), and weight (p = 0.002). In the PL-D group the main primary renal diseases were glomerular and polycystic disease, whereas interstitial and diabetic nephropathy were higher in UNPL-D group (p = 0.005). Multivariate analysis showed that previous non nephrological follow-up, uraemic symptoms, interstitial nephritis as primary renal disease correlated with UNPL-D initiation, and it was followed by choosing haemodialysis as first RRT. UNPL-D was also associated with increased number of days of hospitalization at the initiation of dialysis, and during the first 6 months (p < 0.001), increase of hospitalization days (p = 0.009), and increased 6-month-mortality (10.2% vs 3.2%) (p = 0.015, log rank test), and three-year mortality (24.2 vs 36.9%) (p = 0.006, log rank test). The costs of UNPL-D were fivefold that of the PL-D group.
UNPL-D has been associated with worse overall clinical conditions at the initiation of chronic replacement therapy, choosing haemodialysis as first RRT, increased morbi-mortality and subsequent increase of costs.
我们研究的目的是分析患者特征、死亡率和成本,所有这些均与开始透析是计划内还是计划外相关。
纳入了1996年至1997年期间在国家卫生系统的五家医院开始接受慢性肾脏替代治疗(RRT)的362例患者(227例男性和135例女性)。排除急性肾衰竭后开始接受RRT的患者。我们对人口统计学特征、开始透析时患者的状况以及治疗6个月和36个月时的结局和成本进行了回顾性分析。根据患者是否有用于开始RRT的血管通路或腹膜通路,将患者分为计划内透析(PL-D)或计划外透析(UNPL-D)。
PL-D组有186例患者(51.4%)开始透析,而UNPL-D组有176例(48.6%)。在后一组中,135例(占总数的37.3%)此前由肾病专家进行过监测,41例(11.3%)在没有先前肾病随访的情况下开始透析。UNPL-D与年龄较大(p < 0.001)、非肾病随访(p < 0.001)、糖尿病(34.7%对22.6%)(p = 0.011)、血液透析作为RRT的首选模式(94.9对81.7%)(p < 0.001)、较高的合并症风险(p < 0.001)、伴有尿毒症症状或液体超负荷开始透析(p < 0.001)、输血需求增加(p < 0.001)以及较低的血清白蛋白(p < 0.001)、肌酐清除率(p < 0.001)、血红蛋白浓度(p < 0.001)和体重(p = 0.002)相关。PL-D组的主要原发性肾脏疾病是肾小球疾病和多囊肾病,而UNPL-D组的间质性和糖尿病肾病更多见(p = 0.005)。多变量分析显示,先前的非肾病随访、尿毒症症状、原发性肾脏疾病为间质性肾炎与开始UNPL-D相关,其次是选择血液透析作为首选RRT。UNPL-D还与透析开始时以及前6个月住院天数增加(p < 0.001)、住院天数增加(p = 0.009)以及6个月死亡率增加(10.2%对3.2%)(p = 0.015,对数秩检验)和三年死亡率增加(24.2对36.9%)(p = 0.006,对数秩检验)相关。UNPL-D的成本是PL-D组的五倍。
计划外透析与慢性替代治疗开始时总体临床状况较差、选择血液透析作为首选RRT、发病率和死亡率增加以及随后成本增加相关。